-
The Festival of Genomics returns to London to celebrate UK progress in precision medicine
The Festival of Genomics 2020 returns to London for the fifth year to immerse you in the research, innovation and results taking place within genomics today. As the UK’s largest genomics event, the festival is a unique experience – a crossroads for the entire genomics ecosystem to discover, meet, learn, have fun and celebrate. Driven by a social…
-
UKI2S, Catapult Ventures and Jonathan Milner invest £500K in gene modulation newcomer Pencil Biosciences
Alderley Park, Cheshire, UK, 11th December 2019 / Sciad Newswire / UK Innovation & Science Seed Fund (UKI2S), Catapult Ventures’ GM&C Life Sciences Fund and Jonathan Milner are pleased to announced an investment in Pencil Biosciences, a novel gene modulation company based at Alderley Park, Cheshire. A further investment by o2h Ventures anticipated shortly will complete a seed round of £500k that will enable the…
-
Kristian Jürgensen promoted to Chief Commercial Officer as The RSA Group expands
London, UK, 10th December 2019 / Sciad Newswire / The RSA Group, a leading Life Sciences executive search firm, announced today that Kristian Jürgensen has been promoted to Chief Commercial Officer effective as of December 2019. Kristian joined the company as Managing Partner for Germany and Switzerland in May 2019 and has proved himself to be a phenomenal driver…
-
Hypha Discovery announces “One-Stop Metabolite Shop” solution to support pharmaceutical and agrochemical R&D
Slough, UK, 3rd December 2019 / Sciad Newswire / Hypha Discovery Limited, a leading specialist CRO, has launched its “One-Stop Metabolite Shop” to provide a complete solution for provision of small molecule drug metabolites to pharmaceutical and agrochemical companies worldwide. Over the last eight years, Hypha has developed a microbial and mammalian biotransformation platform, with a proven reputation for biotransforming…
-
One Nucleus announces finalists of the BioNewsRound Award
London, UK, 28th November 2019 / Sciad Newswire / One Nucleus reveals the finalists of its annual BioNewsRound Award, recognising life science companies that have announced exciting developments for patients and the sector. The finalists will present at Genesis 2019 where the winner will be announced. Companies were nominated for their most important news stories from the last year. These were assessed…
-
Prokarium announces MHRA acceptance to run Phase I trial of lead vaccine against enteric fever
London, UK, 26th November 2019 / Sciad Newswire / Prokarium, a private biotechnology company developing vaccines against infectious diseases and immunotherapy for solid tumors, has received Clinical Trial Authorization (CTA) acceptance from the UK Medicines and Healthcare products Regulatory Agency (MHRA) to run a first-in-human Phase I trial with Entervax™, a bivalent vaccine against enteric fever. Prokarium anticipates…
-
Pharma Integrates attracts record number of delegates
London, UK, 21st November 2019 / Sciad Newswire / Pharma Integrates 2019, which took place on 18th and 19th November, saw over 450 delegates from biotech, pharma, CDMOs and the supply chain come together to debate and share insights on key topics currently affecting the industry. The phenomenally successful two-day event, now in its 8th year, opened with a welcome address from…
-
Digital Health – Defining a New Industry of Healthcare Companies
The inaugural DigiHealth Leaders conference, organised by LSX Leaders, arrived in London’s Royal Victoria Dock last week. A showcase of the world’s latest and most innovative digital healthcare technology applications, the two-day event was sure to be inspiring. With devices and applications targeting everything from prevention of acute respiratory disease, to improving quality of life for “locked-in” patients,…
-
UKI2S wins Best Sector Support Organisation at the OBN Awards
London, UK, 8th November 2019 / Sciad Newswire / UK Innovation & Science Seed Fund (UKI2S) is delighted to announce it is has been awarded ‘Best Sector Support Organisation’ at the 11th Annual OBN Awards celebration last night. UKI2S was nominated on the strength of its work nurturing new businesses in life sciences arising from the great…
-
Making medicines of the future: Watson-Marlow Fluid Technology Group launches sterile ReNu SU Technology cartridge assemblies for the Quantum pump Primary tabs
Provided with aseptic connectors and sterility assurance claim to ensure secure fluid path connections. Falmouth, UK, 7th November 2019 / Sciad Newswire / The growth of personalised medicines, such as cell and gene therapies, brings new challenges to the biopharmaceutical manufacturing sector. Watson-Marlow Fluid Technology Group (WMFTG) is introducing the ReNu SU cartridge assemblies with a 10-6 SAL…